TransMedics to Present at the Oppenheimer's 32nd Annual Healthcare Conference

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX) will present virtually at the Oppenheimer 32nd Annual Healthcare Conference on March 16, 2022, at 3:20 p.m. EST. The company is at the forefront of improving organ transplant therapy for patients with end-stage heart, lung, and liver failure. A live and archived webcast of the presentation will be available on their Investors section. TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs, enhancing organ viability and increasing usage rates.

ANDOVER, Mass., March 1, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming Oppenheimer 32^nd Annual Healthcare Conference. Management is scheduled to present on Wednesday, March 16, 2022, at 3:20 p.m. Eastern Standard Time.

Event: Oppenheimer's 32^nd Annual Healthcare Conference
Date: Wednesday, March 16, 2022
Time: 3:20 p.m. EST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-oppenheimers-32nd-annual-healthcare-conference-301493295.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics presenting at the Oppenheimer 32nd Annual Healthcare Conference?

TransMedics will present on March 16, 2022, at 3:20 p.m. EST.

Where can I watch the TransMedics presentation from the Oppenheimer Conference?

The presentation will be available live and archived on the Investors section of the TransMedics website.

What is TransMedics' focus in organ transplantation?

TransMedics focuses on transforming organ transplant therapy for patients with end-stage heart, lung, and liver failure through innovative technologies.

What technologies does TransMedics develop for organ preservation?

TransMedics develops technologies for portable extracorporeal warm perfusion to preserve organ quality and assess viability before transplantation.

What stock symbol is associated with TransMedics?

TransMedics is traded under the stock symbol TMDX.